CHOP has a team of full-time genetic counselors dedicated only to fetal patients. Learn how they support families in prenatal counseling.

Since infants rely on antibodies passed from mother to baby during pregnancy, the findings suggest a need for alternative strategies for boosting infant immunity in the event of an outbreak.

The more we know; the more we can help. Clinical and research leaders from CHOP’s Mitochondrial Medicine team encourage families to join mitoSHARE, a worldwide patient-populated registry initiative stewarded by the United Mitochondrial Disease Foundation (UMDF).

Here are resources to help frontline clinicians diagnose and manage developmental disorders and behavioral concerns.

Click through our online courses to learn more about the latest advances in pediatric care, clinical educational resources and more.

Showcasing its longstanding partnership with the United Arab Emirates (UAE) Emirates Health Services (EHS), Children’s Hospital of Philadelphia (CHOP) will exhibit thought-leading clinical research in the EHS booth at the Arab Health 2023 Exhibition and Congress, taking place this week in Dubai.

CHOP will be a provider in Independence Blue Cross’s new Advanced Network for Gene-Based Therapeutics, effective March 1, 2023.

Phase three of the Management of Myelomeningocele Study (MOMS), known as “MOMS3,” is a study monitoring the health outcomes of participants ages15-24.

With support from Jazz Pharmaceuticals, the grant will fund a SU2C Catalyst® Research Team led by Dr. Grohar; the team will investigate new, targeted treatments for patients 10 years and older with Ewing sarcoma.

CHOP researchers have developed a custom-built application to automate determination of engraftment, a key outcome after hematopoietic stem cell transplant.